2-chloro-4-amino-6,7-dimethoxyquinazoline;6,7-Dimethoxyquinazoline-2,4-dione;Prazosin Hydrochloride;Terazosin hydrochloride dihydrate;Tienilic intermediates;Maleimide series etc.
more >
Year of Establishment:
2000
Total Assets(USD):
5,000,000 to 5,999,999
Total Number of Staff:
100 to 149
Main Competitive Advantages:
Other Competitive Advantages:
High quality product, in time supply;
Patents and Copyrights:
Patent No. of ROS for 2-Chloro-4-Amino-6,7 Dimethoxyquinazoline: 2008100702545;
(The patent application is during the substantial examination process.)
Patent No.for a method of synthesizing the compouds and intermediates which including Hydroxyaetic
Business Type:
Manufacturer
R&D capacity:
Annual Turnover(USD):
Choose not to disclose
Main Sales Markets:
Central/South America,Western Europe,Eastern Europe,Asia,Middle East
Other Competitive Advantages:
High quality product, in time supply;
Patents and Copyrights:
Patent No. of ROS for 2-Chloro-4-Amino-6,7 Dimethoxyquinazoline: 2008100702545;
(The patent application is during the substantial examination process.)
Patent No.for a method of synthesizing the compouds and intermediates which including Hydroxyaetic